openPR Logo
Press release

Mitral Valve Regurgitation Treatment Market Grows with Adoption of Transcatheter Therapies and Aging Patient Population | Abbott Laboratories, Edwards Lifesciences Corporation, LivaNova PLC

07-28-2025 09:57 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Mitral Valve Regurgitation Treatment Market

Mitral Valve Regurgitation Treatment Market

Global Mitral Valve Regurgitation Treatment Market is expected to grow at a CAGR of 8.5 during the forecast period 2025-2033.

Mitral Valve Regurgitation Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/mitral-valve-regurgitation-treatment-market?ophp

Mitral Valve Regurgitation occurs when the heart's mitral valve doesn't close properly, causing blood leakage. The treatment landscape is evolving with surgical valve repair, replacement options, and minimally invasive procedures like transcatheter mitral valve repair (TMVR), which are driving significant market growth globally.

Mitral Valve Regurgitation Treatment Market Competitors Overview:

Abbott Laboratories, Edwards Lifesciences Corporation, LivaNova PLC, Medtronic, Neovasc Inc., NeoChord, Inc., HVR Cardio, Cardiac Dimensions, Cardiovalve Ltd. and Peijia Medical Limited. among others.

Important Industry Updates of 2024 and 2025:

✅ In May 2025, The FDA approved the TendyneTM TMVR system for patients with severe mitral annular calcification (MAC) who are not surgical candidates or not suitable for MitraClip® repair. This represents the first FDA‐approved transcatheter mitral valve replacement device for specific high‐risk patients with MR or mitral stenosis.

✅ Edwards Lifesciences (widely known for TAVR and MitraClip) increased its 2025 guidance for its Transcatheter Mitral & Tricuspid Therapies (TMTT) business to $530-550 million, reflecting ongoing growth ahead of new device launches like Tendyne.

Methodology and Scope

The Mitral Valve Regurgitation Treatment Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/mitral-valve-regurgitation-treatment-market?ophp

Mitral Valve Regurgitation Treatment Market Segments Overview:

∎ By Disease Type (Degenerative Mitral Regurgitation, Functional Mitral Regurgitation)
∎ By Treatment Type (Surgery, Mitral Transcatheter Edge-to-Edge Repair (TEER), Transcatheter Mitral Valve Replacement (TMVR), Drugs, Others)
∎ By Sales Channel (End-User, Distribution Channel)

Regional Overview for Mitral Valve Regurgitation Treatment Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=mitral-valve-regurgitation-treatment-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!"
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mitral Valve Regurgitation Treatment Market Grows with Adoption of Transcatheter Therapies and Aging Patient Population | Abbott Laboratories, Edwards Lifesciences Corporation, LivaNova PLC here

News-ID: 4122117 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven by Automation and Efficiency Demands | DataM Intelligence
United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven …
The global Legal AI Software Market reached USD 0.5 billion in 2022 and is projected to reach USD 3.7 billion by 2030, growing at a CAGR of 28.7% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Thomson Reuters launched its next-generation AI contract review platform, reducing document analysis time by 80% for corporate legal teams. ✅ In August 2025, A coalition of top
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, Driven by Grid Optimization and Predictive Maintenance | DataM Intelligence
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, D …
The global AI In Renewable Energy Market reached US$ 0.85 billion in 2024 and is projected to reach US$ 4.85 billion by 2032, growing at a CAGR of 24.32% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The National Renewable Energy Laboratory (NREL) launched an AI platform that improved solar generation forecasts by 30%, significantly enhancing grid reliability. ✅ In August 2025,
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching US$ 99.48 billion by 2032 | DataM Intelligence
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching U …
The global AI In Energy Market reached US$ 9.89 billion in 2024 and is projected to reach US$ 99.48 billion by 2032, growing at a CAGR of 33.45% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Google DeepMind partnered with a major US utility to implement AI for real-time grid optimization, reducing energy losses by 15%. ✅ In
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Mar …
Market Size and Growth The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029) Key Development: United States: Recent Industry Developments ✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions. ✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6

All 5 Releases


More Releases for Mitral

Impact Of Rising Prevalence Of Vascular Heart Diseases On The Mitral Valve Disea …
What industry-specific factors are fueling the growth of the mitral valve disease market? The growing prevalence of vascular heart diseases is expected to boost the mitral valve disease market. Vascular heart diseases, including ischemic heart disease and hypertension, can lead to mitral valve disease by affecting the heart's structure and function. The Australian Bureau of Statistics reported an increase in cardiovascular disease-related deaths from 2021 to 2022, indicating the rising incidence
Impact Of Rising Prevalence Of Vascular Heart Diseases On The Mitral Valve Disea …
What Are the Projected Growth and Market Size Trends for the Mitral Valve Disease Market? In the past few years, the market size for mitral valve disease has seen a formidable growth. It is projected to increase from $3 billion in 2024 to $3.3 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The historic growth can be credited to efforts in patient education, robust reimbursement policies and
Emerging Therapies and Innovations in Mitral Valve Disease Market
Mitral valve disease, a prevalent cardiovascular disorder, presents a significant health burden worldwide. As medical science advances, a wave of innovative therapies and technologies is reshaping the landscape of mitral valve disease treatment. This report delves into the latest breakthroughs, therapies, and interventions that are driving the evolution of the mitral valve disease market. By examining emerging trends, clinical trials, and advancements, this report offers a comprehensive analysis of the
Transcatheter Mitral Valve Replacement Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Transcatheter Mitral Valve Replacement Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-transcatheter-mitral-valve-replacement-tmvr-market_p104117.html   Mitral valve is located on the
Transcatheter Mitral Valve Repair & Replacement Market - Evolution in Geriatric …
The Transcatheter Mitral Repair and Replacement Market is expected to reach $ 1,878 million (both repair and replacement valves) by 2023, with a CAGR of 30.0% from 2017 to 2023. Mechanical valve segments accounted for the largest share of the entire market in 2016. The mitral valve is a heart valve that sends blood from one chamber of the heart to the left atrium to another valve called the left ventricle.
Global Transcatheter Mitral Valve Replacement Sales Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Global Transcatheter Mitral Valve Replacement Sales Market Report 2017" Description This report studies sales (consumption) of Transcatheter Mitral Valve Replacement in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Abbott Laboratories Edwards Lifesciences Micro Interventional Devices Neovasc MitrAssist NaviGate Cardiac Structures Valtech ... Market Segment by Regions, this report splits Global